Increased expression of RXRα in dementia: An early harbinger for the cholesterol dyshomeostasis?

Molecular Neurodegeneration

Volumn 5, Issue 1, 2010, Pages

  Akram, Afia ^a   Schmeidler, James ^a   Katsel, Pavel ^a   Hof, Patrick R ^a   Haroutunian, Vahram ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; APOENZYME; CELL NUCLEUS RECEPTOR; CHOLESTEROL; HETERODIMER; RETINOID X RECEPTOR ALPHA;

ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; DEMENTIA; GENE EXPRESSION; HIPPOCAMPUS; HOMEOSTASIS; HUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION;

EID: 77956526504     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-5-36     Document Type: Article

References (97)

1. The RXR heterodimers and orphan receptors. DJ Mangelsdorf RM Evans, Cell 1995 83 6 841 850 10.1016/0092-8674(95)90200-7 8521508
2. A novel orphan receptor specific for a subset of thyroid hormone-responsive elements and its interaction with the retinoid/thyroid hormone receptor subfamily. R Apfel D Benbrook E Lernhardt MA Ortiz G Salbert M Pfahl, Mol Cell Biol 1994 14 10 7025 7035 7935418
3. LXR, a nuclear receptor that defines a distinct retinoid response pathway. PJ Willy K Umesono ES Ong RM Evans RA Heyman DJ Mangelsdorf, Genes Dev 1995 9 9 1033 1045 10.1101/gad.9.9.1033 7744246
4. Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. JM Lehmann SA Kliewer LB Moore TA Smith-Oliver BB Oliver JL Su SS Sundseth DA Winegar DE Blanchard TA Spencer TM Willson, J Biol Chem 1997 272 6 3137 3140 10.1074/jbc.272.6.3137 9013544
5. Orphan nuclear receptors as eLiXiRs and FiXeRs of sterol metabolism. TT Lu JJ Repa DJ Mangelsdorf, J Biol Chem 2001 276 41 37735 37738 11459853
6. The LXRs: a new class of oxysterol receptors. DJ Peet BA Janowski DJ Mangelsdorf, Curr Opin Genet Dev 1998 8 5 571 575 10.1016/S0959-437X(98)80013-0 9794827
7. The role of orphan nuclear receptors in the regulation of cholesterol homeostasis. JJ Repa DJ Mangelsdorf, Annu Rev Cell Dev Biol 2000 16 459 481 10.1146/annurev.cellbio.16.1.459 11031244
8. Regulation of cholesterol homeostasis by the liver X receptors in the central nervous system. KD Whitney MA Watson JL Collins WG Benson TM Stone MJ Numerick TK Tippin JG Wilson DA Winegar SA Kliewer, Mol Endocrinol 2002 16 6 1378 1385 10.1210/me.16.6.1378 12040022
9. Retinoid X receptors: X-ploring their (patho)physiological functions. A Szanto V Narkar Q Shen IP Uray PJ Davies L Nagy, Cell Death Differ 2004 11 Suppl 2 126 S143 10.1038/sj.cdd.4401533 15608692
10. Nuclear receptors and lipid physiology: opening the X-files. A Chawla JJ Repa RM Evans DJ Mangelsdorf, Science 2001 294 5548 1866 1870 10.1126/science.294.5548.1866 11729302
11. A transcriptional co-repressor that interacts with nuclear hormone receptors. JD Chen RM Evans, Nature 1995 377 6548 454 457 10.1038/377454a0 7566127
12. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. AJ Horlein AM Naar T Heinzel J Torchia B Gloss R Kurokawa A Ryan Y Kamei M Soderstrom CK Glass, Nature 1995 377 6548 397 404 10.1038/377397a0 7566114
13. The coregulator exchange in transcriptional functions of nuclear receptors. CK Glass MG Rosenfeld, Genes Dev 2000 14 2 121 141 10652267
14. Mechanism of the nuclear receptor molecular switch. L Nagy JW Schwabe, Trends Biochem Sci 2004 29 6 317 324 10.1016/j.tibs.2004.04.006 15276186
15. The phantom ligand effect: allosteric control of transcription by the retinoid X receptor. IG Schulman C Li JW Schwabe RM Evans, Genes Dev 1997 11 3 299 308 10.1101/gad.11.3.299 9030683
16. Role of LXRs in control of lipogenesis. JR Schultz H Tu A Luk JJ Repa JC Medina L Li S Schwendner S Wang M Thoolen DJ Mangelsdorf KD Lustig B Shan, Genes Dev 2000 14 22 2831 2838 10.1101/gad.850400 11090131
17. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. P Costet Y Luo N Wang AR Tall, J Biol Chem 2000 275 36 28240 28245 10858438
18. Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta. JJ Repa KE Berge C Pomajzl JA Richardson H Hobbs DJ Mangelsdorf, J Biol Chem 2002 277 21 18793 18800 10.1074/jbc. M109927200 11901146
19. Positive and negative regulation of squalene synthase (ERG9), an ergosterol biosynthetic gene, in Saccharomyces cerevisiae. MA Kennedy M Bard, Biochim Biophys Acta 2001 1517 2 177 189 11342098
20. LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes. BA Laffitte JJ Repa SB Joseph DC Wilpitz HR Kast DJ Mangelsdorf P Tontonoz, Proc Natl Acad Sci USA 2001 98 2 507 512 10.1073/pnas.021488798 11149950
21. Liver X receptors are regulators of adipocyte gene expression but not differentiation: identification of apoD as a direct target. S Hummasti BA Laffitte MA Watson C Galardi LC Chao L Ramamurthy JT Moore P Tontonoz, J Lipid Res 2004 45 4 616 625 10.1194/jlr.M300312-JLR200 14703507
22. Phospholipid transfer protein is regulated by liver X receptors in vivo. G Cao TP Beyer XP Yang RJ Schmidt Y Zhang WR Bensch RF Kauffman H Gao TP Ryan Y Liang PI Eacho XC Jiang, J Biol Chem 2002 277 42 39561 39565 10.1074/jbc.M207187200 12177004
23. Sterol upregulation of human CETP expression in vitro and in transgenic mice by an LXR element. Y Luo AR Tall, J Clin Invest 2000 105 4 513 520 10.1172/JCI8573 10683381
24. Induction of the cholesterol transporter ABCA1 in central nervous system cells by liver X receptor agonists increases secreted Abeta levels. H Fukumoto A Deng MC Irizarry ML Fitzgerald GW Rebeck, J Biol Chem 2002 277 50 48508 48513 10.1074/jbc.M209085200 12384498
25. A liver X receptor and retinoid X receptor heterodimer mediates apolipoprotein E expression, secretion and cholesterol homeostasis in astrocytes. Y Liang S Lin TP Beyer Y Zhang X Wu KR Bales RB DeMattos PC May SD Li XC Jiang PI Eacho G Cao SM Paul, J Neurochem 2004 88 3 623 634 10.1111/j.1471-4159.2004.02183.x 14720212
26. LXRs: new therapeutic targets in atherosclerosis? SB Joseph P Tontonoz, Curr Opin Pharmacol 2003 3 2 192 197 10.1016/S1471-4892(03)00009-2 12681243
27. Liver X receptors in the central nervous system: from lipid homeostasis to neuronal degeneration. L Wang GU Schuster K Hultenby Q Zhang S Andersson JA Gustafsson, Proc Natl Acad Sci USA 2002 99 21 13878 13883 10.1073/pnas.172510899 12368482
28. Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. DJ Mangelsdorf U Borgmeyer RA Heyman JY Zhou ES Ong AE Oro A Kakizuka RM Evans, Genes Dev 1992 6 3 329 344 10.1101/gad.6.3.329 1312497
29. Differential expression of retinoid receptors in the adult mouse central nervous system. W Krezel P Kastner P Chambon, Neuroscience 1999 89 4 1291 1300 10.1016/S0306-4522(98)00342-X 10362315
30. Role of retinoids in the CNS: differential expression of retinoid binding proteins and receptors and evidence for presence of retinoic acid. RH Zetterstrom E Lindqvist UA Mata de A Tomac U Eriksson T Perlmann L Olson, Eur J Neurosci 1999 11 2 407 416 10.1046/j.1460-9568.1999.00444.x 10051741
31. Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS. S Moreno S Farioli-Vecchioli MP Ceru, Neuroscience 2004 123 1 131 145 10.1016/j.neuroscience.2003.08.064 14667448
32. Transcriptional vulnerability of brain regions in Alzheimer's disease and dementia. V Haroutunian P Katsel J Schmeidler, Neurobiol Aging 2009 30 4 561 73 10.1016/j.neurobiolaging.2007.07.021 17845826
33. Changes in the expression of genes involved in cholesterol trafficking with the progression of Alzheimer's disease [abstract]. A Akram P Katsel PR Hof V Haroutunian, Society for Neuroscience Abstracts 2007 795.9/N1
34. Coordinated transcriptional and translational changes in cholesterol transporters correlate with cognitive decline in Alzheimer's disease [abstract]. A Akram P Katsel PR Hof V Haroutunian, Society for Neuroscience Abstracts 2008 45.7/U31
35. Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices. DA Lewis MJ Campbell RD Terry JH Morrison, J Neurosci 1987 7 6 1799 1808 2439665
36. Visual retinocortical function in dementia of the Alzheimer type. H Kergoat MJ Kergoat L Justino H Chertkow A Robillard H Bergman, Gerontology 2002 48 4 197 203 10.1159/000058350 12053107
37. Neuro-ophthalmic findings in the visual variant of Alzheimer's disease. AG Lee CO Martin, Ophthalmology 2004 111 2 376 380 10.1016/S0161-6420(03)00732-2 15019393
38. Visual attention deficits in Alzheimer's disease: an fMRI study. J Hao K Li K Li D Zhang W Wang Y Yang B Yan B Shan X Zhou, Neurosci Lett 2005 385 1 18 23 10.1016/j.neulet.2005.05.028 15970381
39. Visual receptive field organization. W Bair, Curr Opin Neurobiol 2005 15 4 459 464 10.1016/j.conb.2005.07.006 16023850
40. A grading system of Alzheimer disease lesions in neocortical areas. WP Metsaars JJ Hauw ME van Welsem C Duyckaerts, Neurobiol Aging 2003 24 4 563 572 10.1016/S0197-4580(02)00134-3 12714113
41. Increased expression of cholesterol transporter ABCA1 is highly correlated with severity of dementia in AD hippocampus. A Akram J Schmeidler P Katsel PR Hof V Haroutunian, Brain Research 2010 1318 167 177 10.1016/j.brainres.2010.01.006 20079340
42. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. M Bodzioch E Orso J Klucken T Langmann A Bottcher W Diederich W Drobnik S Barlage C Buchler M Porsch-Ozcurumez WE Kaminski HW Hahmann K Oette G Rothe C Aslanidis KJ Lackner G Schmitz, Nat Genet 1999 22 4 347 351 10.1038/11914 10431237
43. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. A Brooks-Wilson M Marcil SM Clee LH Zhang K Roomp M van Dam L Yu C Brewer JA Collins HO Molhuizen O Loubser BF Ouelette K Fichter KJ Ashbourne-Excoffon CW Sensen S Scherer S Mott M Denis D Martindale J Frohlich K Morgan B Koop S Pimstone JJ Kastelein MR Hayden, Nat Genet 1999 22 4 336 345 10.1038/11905 10431236 (Pubitemid 29369523)
44. The liver X receptor gene team: potential new players in atherosclerosis. JJ Repa DJ Mangelsdorf, Nat Med 2002 8 11 1243 1248 10.1038/nm1102-1243 12411951
45. Cholesterol in Alzheimer's disease. LA Shobab GY Hsiung HH Feldman, Lancet Neurol 2005 4 12 841 852 10.1016/S1474-4422(05)70248-9 16297842
46. 22R-hydroxycholesterol and 9-cis-retinoic acid induce ATP-binding cassette transporter A1 expression and cholesterol efflux in brain cells and decrease amyloid beta secretion. RP Koldamova IM Lefterov MD Ikonomovic J Skoko PI Lefterov BA Isanski ST DeKosky JS Lazo, J Biol Chem 2003 278 15 13244 13256 10.1074/jbc.M300044200 12547833
47. Expression of liver X receptor target genes decreases cellular amyloid beta peptide secretion. Y Sun J Yao TW Kim AR Tall, J Biol Chem 2003 278 30 27688 27694 10.1074/jbc.M300760200 12754201
48. The liver X receptor ligand T0901317 decreases amyloid beta production in vitro and in a mouse model of Alzheimer's disease. RP Koldamova IM Lefterov M Staufenbiel D Wolfe S Huang JC Glorioso M Walter MG Roth JS Lazo, J Biol Chem 2005 280 6 4079 4088 10.1074/jbc.M411420200 15557325
49. The LXR agonist TO901317 selectively lowers hippocampal Abeta42 and improves memory in the Tg2576 mouse model of Alzheimer's disease. DR Riddell H Zhou TA Comery E Kouranova CF Lo HK Warwick RH Ring Y Kirksey S Aschmies J Xu K Kubek WD Hirst C Gonzales Y Chen E Murphy S Leonard D Vasylyev A Oganesian RL Martone MN Pangalos PH Reinhart JS Jacobsen, Mol Cell Neurosci 2007 34 4 621 628 10.1016/j.mcn.2007.01.011 17336088
50. Cholesterol independent effect of LXR agonist TO-901317 on gamma-secretase. C Czech MP Burns L Vardanian A Augustin H Jacobsen K Baumann GW Rebeck, J Neurochem 2007 101 4 929 936 10.1111/j.1471-4159.2007.04467.x 17472585
51. T0901317 is a potent PXR ligand: implications for the biology ascribed to LXR. N Mitro L Vargas R Romeo A Koder E Saez, FEBS Lett 2007 581 9 1721 1726 10.1016/j.febslet.2007.03.047 17418145
52. T0901317 is a dual LXR/FXR agonist. KA Houck KM Borchert CD Hepler JS Thomas KS Bramlett LF Michael TP Burris, Mol Genet Metab 2004 83 1-2 184 187 10.1016/j.ymgme.2004.07.007 15464433
53. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha. DJ Peet SD Turley W Ma BA Janowski JM Lobaccaro RE Hammer DJ Mangelsdorf, Cell 1998 93 5 693 704 10.1016/S0092- 8674(00)81432-4 9630215
54. A novel liver X receptor agonist establishes species differences in the regulation of cholesterol 7alpha-hydroxylase (CYP7a). JG Menke KL Macnaul NS Hayes J Baffic YS Chao A Elbrecht LJ Kelly MH Lam A Schmidt S Sahoo J Wang SD Wright P Xin G Zhou DE Moller CP Sparrow, Endocrin 2002 143 7 2548 2558 10.1210/en.143.7.2548 (Pubitemid 34701318)
55. Synthetic LXR agonists increase LDL in CETP species. PH Groot NJ Pearce JW Yates C Stocker C Sauermelch CP Doe RN Willette A Olzinski T Peters D d'Epagnier KO Morasco JA Krawiec CL Webb K Aravindhan B Jucker M Burgert C Ma JP Marino JL Collins CH Macphee SK Thompson M Jaye, J Lipid Res 2005 46 10 2182 2191 10.1194/jlr.M500116-JLR200 16024916
56. Cholesteryl ester transfer protein modulates the effect of liver X receptor agonists on cholesterol transport and excretion in the mouse. D Masson B Staels T Gautier C Desrumaux A Athias GN Le M Schneider Z Zak L Dumont V Deckert A Tall XC Jiang L Lagrost, J Lipid Res 2004 45 3 543 550 10.1194/jlr.M300432-JLR200 14679166
57. Rediscovery of cerebrosterol. I Bjorkhem, Lipids 2007 42 1 5 14 10.1007/s11745-006-1003-2 17393206
58. Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients. D Lutjohann A Papassotiropoulos I Bjorkhem S Locatelli M Bagli RD Oehring U Schlegel F Jessen ML Rao K von Bergmann R Heun, J Lipid Res 2000 41 2 195 198 10681402
59. 24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia. A Papassotiropoulos D Lutjohann M Bagli S Locatelli F Jessen R Buschfort U Ptok I Bjorkhem K von Bergmann R Heun, J Psychiatr Res 2002 36 1 27 32 10.1016/S0022-3956(01)00050-4 11755458
60. 24(S)-Hydroxycholesterol participates in a Liver X Receptor-controlled pathway in astrocytes that regulates Apolipoprotein E-mediated cholesterol efflux. K Abildayeva PJ Jansen V Hirsch-Reinshagen VW Bloks AH Bakker FC Ramaekers J De Vente AK Groen CL Wellington F Kuipers M Mulder, J Biol Chem 2006 281 18 12799 12808 10.1074/jbc.M601019200 16524875
61. Plasma 24S-hydroxycholesterol: a peripheral indicator of neuronal degeneration and potential state marker for Alzheimer's disease. A Papassotiropoulos D Lutjohann M Bagli S Locatelli F Jessen ML Rao W Maier I Bjorkhem BK von R Heun, NeuroReport 2000 11 9 1959 1962 10.1097/00001756- 200006260-00030 10884051
62. Ligand-independent coregulator recruitment by the triply activatable OR1/retinoid X receptor-alpha nuclear receptor heterodimer. FF Wiebel KR Steffensen E Treuter D Feltkamp JA Gustafsson, Mol Endocrinol 1999 13 7 1105 1118 10.1210/me.13.7.1105 10406462
63. RXR heterodimerization allosterically activates LXR binding to the second NR box of activating signal co-integrator-2. YL Son OG Park GS Kim JW Lee YC Lee, Biochem J 2008 410 2 319 330 10.1042/BJ20070837 18031289
64. Heterodimeric interaction between retinoid X receptor alpha and orphan nuclear receptor OR1 reveals dimerization-induced activation as a novel mechanism of nuclear receptor activation. FF Wiebel JA Gustafsson, Mol Cell Biol 1997 17 7 3977 3986 9199332
65. An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. BA Janowski PJ Willy TR Devi JR Falck DJ Mangelsdorf, Nature 1996 383 6602 728 731 10.1038/383728a0 8878485
66. Unique requirements for retinoid-dependent transcriptional activation by the orphan receptor LXR. PJ Willy DJ Mangelsdorf, Genes Dev 1997 11 3 289 298 10.1101/gad.11.3.289 9030682
67. Structural determinants of allosteric ligand activation in RXR heterodimers. AI Shulman C Larson DJ Mangelsdorf R Ranganathan, Cell 2004 116 3 417 429 10.1016/S0092-8674(04)00119-9 15016376
68. LRP1 controls cPLA2 phosphorylation, ABCA1 expression and cellular cholesterol export. L Zhou HY Choi WP Li F Xu J Herz, PLoS ONE 2009 4 8 6853 10.1371/journal.pone.0006853 19718435
69. Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. M Simons P Keller B De Strooper K Beyreuther CG Dotti K Simons, Proc Natl Acad Sci USA 1998 95 11 6460 6464 10.1073/pnas.95.11.6460 9600988
70. Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. K Fassbender M Simons C Bergmann M Stroick D Lutjohann P Keller H Runz S Kuhl T Bertsch K von Bergmann M Hennerici K Beyreuther T Hartmann, Proc Natl Acad Sci USA 2001 98 10 5856 5861 10.1073/pnas.081620098 11296263
71. Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts. R Ehehalt P Keller C Haass C Thiele K Simons, J Cell Biol 2003 160 1 113 123 10.1083/jcb.200207113 12515826
72. Attenuation of neuroinflammation and Alzheimer's disease pathology by liver x receptors. N Zelcer N Khanlou R Clare Q Jiang EG Reed-Geaghan GE Landreth HV Vinters P Tontonoz, Proc Natl Acad Sci USA 2007 104 25 10601 10606 10.1073/pnas.0701096104 17563384
73. Neuronal membrane cholesterol loss enhances amyloid peptide generation. J Abad-Rodriguez MD Ledesma K Craessaerts S Perga M Medina A Delacourte C Dingwall B De Strooper CG Dotti, J Cell Biol 2004 167 5 953 960 10.1083/jcb.200404149 15583033
74. Lovastatin enhances Abeta production and senile plaque deposition in female Tg2576 mice. IH Park EM Hwang HS Hong JH Boo SS Oh J Lee MW Jung OY Bang SU Kim I Mook-Jung, Neurobiol Aging 2003 24 5 637 643 10.1016/S0197-4580(02) 00155-0 12885571
75. Raft disorganization leads to reduced plasmin activity in Alzheimer's disease brains. MD Ledesma J Abad-Rodriguez C Galvan E Biondi P Navarro A Delacourte C Dingwall CG Dotti, EMBO Rep 2003 4 12 1190 1196 10.1038/sj.embor.7400021 14618158
76. Neurofibrillary tangles in nondemented elderly subjects and mild Alzheimer disease. V Haroutunian DP Purohit DP Perl D Marin K Khan M Lantz KL Davis RC Mohs, Arch Neurol 1999 56 6 713 718 10.1001/archneur.56.6.713 10369312
77. Cholinergic markers in elderly patients with early signs of Alzheimer disease. KL Davis RC Mohs D Marin DP Purohit DP Perl M Lantz G Austin V Haroutunian, JAMA 1999 281 15 1401 1406 10.1001/jama.281.15.1401 10217056 (Pubitemid 29190218)
78. Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease. V Haroutunian DP Perl DP Purohit D Marin K Khan M Lantz KL Davis RC Mohs, Arch Neurol 1998 55 9 1185 1191 10.1001/archneur.55.9.1185 9740112
79. Extensive postmortem stability of RNA from rat and human brain. SA Johnson DG Morgan CE Finch, J Neurosci Res 1986 16 1 267 280 10.1002/jnr.490160123 2427740
80. Pre- and postmortem influences on brain RNA. AJ Barton RC Pearson A Najlerahim PJ Harrison, J Neurochem 1993 61 1 1 11 10.1111/j.1471-4159.1993. tb03532.x 7685811
81. Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders. MP Vawter H Tomita F Meng B Bolstad J Li S Evans P Choudary M Atz L Shao C Neal DM Walsh M Burmeister T Speed R Myers EG Jones SJ Watson H Akil WB Bunney, Molecular Psychaitry 2006 11 663 679 10.1038/sj.mp.4001830 (Pubitemid 43989813)
82. Critical factors in gene expression in postmortem human brain: Focus on studies in schizophrenia. BK Lipska A Deep-Soboslay CS Weickert TM Hyde CE Martin MM Herman JE Kleinman, Biol Psychiatry 2006 60 6 650 658 10.1016/j.biopsych.2006.06.019 16997002
83. Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia: a postmortem neuropathologic study of 100 cases. DP Purohit DP Perl V Haroutunian P Powchik M Davidson KL Davis, Arch Gen Psychiatry 1998 55 3 205 211 10.1001/archpsyc.55.3.205 9510214
84. A new clinical scale for the staging of dementia. CP Hughes L Berg WL Danziger LA Coben RL Martin, British Journal of Psychiatry 1982 140 566 572 10.1192/bjp.140.6.566 7104545
85. Reliability of the Washington University Clinical Dementia Rating. WJ Burke JP Miller EH Rubin JC Morris LA Coben J Duchek IG Wittels L Berg, Arch Neurol 1988 45 1 31 32 3337672
86. The clinical dementia rating (CDR): current version and scoring rules. JC Morris, Neurology 1993 43 2412 2414 8232972
87. The Clinical Dementia Rating scale: community-based validation of "profound' and "terminal' stages. G Dooneief K Marder MX Tang Y Stern, Neurology 1996 46 6 1746 9 8649584
88. Tau protein abnormalities associated with the progression of alzheimer disease type dementia. V Haroutunian, Neurobiol Aging 2007 28 1 1 7 10.1016/j.neurobiolaging.2005.11.001 16343696
89. Guide to the CERAD protocol for the neuropathological assessment of Alzheimer's disease. SS Mirra FS Vogel A Heyman, CERAD 1987
90. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. SS Mirra A Heyman D McKeel SM Sumi BJ Crain LM Brownlee FS Vogel JP Hughes G van Belle L Berg, Neurology 1991 41 479 486 2011243
91. Neuropathological stageing of Alzheimer-related changes. H Braak E Braak, Acta Neuropathol (Berl) 1991 82 239 259 10.1007/BF00308809
92. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. P Chomczynski N Sacchi, Analyt Biochem 1987 162 156 159 10.1016/0003-2697(87)90021-2 2440339
93. Gain in Brain Immunity in the Oldest-Old Differentiates Cognitively Normal from Demented Individuals. P Katsel W Tan V Haroutunian, PLoS One 2009 4 10 7642 10.1371/journal.pone.0007642 19865478
94. Glutamate synthesis and NMDA receptor and PSD-95 expression in DLPFC and occipital cortices of schizophrenics. S Dracheva SL Elhakem MR Gluck LJ Siever KL Davis V Haroutunian, Society for Neuroscience Abstracts 2001
95. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. J Vandesompele K De Preter F Pattyn B Poppe N Van Roy A De Paepe F Speleman, Genome Biol 2002 3 7 ESEARCH0034 10.1186/gb-2002-3-7-research0034 12184808
96. Schizophrenia and Sex Associated Differences in the Expression of Neuronal and Oligodendrocyte Specific Genes in Individual Thalamic Nuclei. W Byne S Dracheva B Chin JM Schmeidler KL Davis V Haroutunian, Schizo Res 2008 98 1-3 118 128 10.1016/j.schres.2007.09.034 (Pubitemid 350235902)
97. Expression of four housekeeping proteins in elderly patients with schizophrenia. DE Bauer V Haroutunian RE McCullumsmith JH Meador-Woodruff, J Neural Transm 2009 116 4 487 491 10.1007/s00702-008-0143-3 19139805